Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3959 | 2017 |
Vascular dementia J T O'Brien, A Thomas The Lancet 386 (10004), 1698-1706, 2015 | 1283 | 2015 |
Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology GM Goodwin, ... Journal of Psychopharmacology 23 (4), 346-388, 2009 | 672 | 2009 |
Depression and dementia: cause, consequence or coincidence? S Bennett, AJ Thomas Maturitas 79 (2), 184-190, 2014 | 636 | 2014 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial S Banerjee, J Hellier, M Dewey, R Romeo, C Ballard, R Baldwin, ... The Lancet 378 (9789), 403-411, 2011 | 621 | 2011 |
Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis T Wise, J Radua, E Via, N Cardoner, O Abe, TM Adams, F Amico, ... Molecular psychiatry 22 (10), 1455-1463, 2017 | 590 | 2017 |
Research criteria for the diagnosis of prodromal dementia with Lewy bodies IG McKeith, TJ Ferman, AJ Thomas, F Blanc, BF Boeve, H Fujishiro, ... Neurology 94 (17), 743-755, 2020 | 581 | 2020 |
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study AJ Thomas, JT O'Brien, S Davis, C Ballard, R Barber, RN Kalaria, ... Archives of general psychiatry 59 (9), 785-792, 2002 | 473 | 2002 |
Frontotemporal dementia and its subtypes: a genome-wide association study R Ferrari, DG Hernandez, MA Nalls, JD Rohrer, A Ramasamy, JBJ Kwok, ... The Lancet Neurology 13 (7), 686-699, 2014 | 429 | 2014 |
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial C Ballard, M Margallo-Lana, E Juszczak, S Douglas, A Swann, A Thomas, ... Bmj 330 (7496), 874, 2005 | 411 | 2005 |
Increase in interleukin-1β in late-life depression AJ Thomas, S Davis, C Morris, E Jackson, R Harrison, JT O’Brien American Journal of Psychiatry 162 (1), 175-177, 2005 | 411 | 2005 |
Dementia with Lewy bodies: an update and outlook TF Outeiro, DJ Koss, D Erskine, L Walker, M Kurzawa-Akanbi, D Burn, ... Molecular neurodegeneration 14, 1-18, 2019 | 403 | 2019 |
Depression and vascular disease: what is the relationship? AJ Thomas, RN Kalaria, J T O’Brien Journal of affective disorders 79 (1-3), 81-95, 2004 | 401 | 2004 |
Pharmacological management of Lewy body dementia: a systematic review and meta-analysis C Stinton, I McKeith, JP Taylor, L Lafortune, E Mioshi, E Mak, ... American Journal of Psychiatry 172 (8), 731-742, 2015 | 333 | 2015 |
New evidence on the management of Lewy body dementia JP Taylor, IG McKeith, DJ Burn, BF Boeve, D Weintraub, C Bamford, ... The Lancet Neurology 19 (2), 157-169, 2020 | 322 | 2020 |
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 294 | 2021 |
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors LM Allan, EN Rowan, MJ Firbank, AJ Thomas, SW Parry, TM Polvikoski, ... Brain 134 (12), 3716-3727, 2011 | 287 | 2011 |
Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease KE McAleese, L Walker, S Graham, ELJ Moya, M Johnson, D Erskine, ... Acta neuropathologica 134, 459-473, 2017 | 271 | 2017 |
Clinical prevalence of Lewy body dementia JPM Kane, A Surendranathan, A Bentley, SAH Barker, JP Taylor, ... Alzheimer's research & therapy 10, 1-8, 2018 | 265 | 2018 |
Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology JT O’Brien, C Holmes, M Jones, R Jones, G Livingston, I McKeith, P Mittler, ... Journal of Psychopharmacology 31 (2), 147-168, 2017 | 254 | 2017 |